Broder; Samuel

Patent Applications and Registrations

Patent applications and USPTO patent grants for Broder; Samuel.The latest application filed is for "vaccines and methods for prevention and treatment of drug-resistant hiv-1 and hepatitis b virus".

Company Profile

0.22.8

Broder; Samuel - Bethesda MD US
Broder; Samuel - Weston FL
Broder; Samuel - Fort Lauderdale FL
Broder; Samuel - Ft. Lauderdale FL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Vaccines and methods for prevention and treatment of drug-resistant HIV-1 and hepatitis B virus Grant 9,474,793 - Catanzaro , et al. October 25, 2	2016-10-25
Vaccines And Methods For Prevention And Treatment Of Drug-resistant Hiv-1 And Hepatitis B Virus App 20090317418 - Catanzaro; Andrew ; et al.	2009-12-24
Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents App 20070060635 - Broder; Samuel ; et al.	2007-03-15
Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents Grant 7,041,640 - Broder , et al. May 9, 2	2006-05-09
Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents App 20050238634 - Broder, Samuel ; et al.	2005-10-27
Method and compositions for administering taxanes orally to human patients Grant 6,936,583 - Broder , et al. August 30, 2	2005-08-30
Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents Grant 6,818,615 - Broder , et al. November 16, 2	2004-11-16
Method, compositions and kits for increasing the oral bioavailability or pharmaceutical agents App 20040176439 - Broder, Samuel ; et al.	2004-09-09
Method and compositions for administering taxanes orally to human patients App 20040171532 - Broder, Samuel ; et al.	2004-09-02
Method and compositions for administering taxanes orally to human patients Grant 6,730,698 - Broder , et al. May 4, 2	2004-05-04
Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents Grant 6,610,735 - Broder , et al. August 26, 2	2003-08-26
Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents App 20030069301 - Broder, Samuel ; et al.	2003-04-10
Method and compositions for administering taxanes orally to human patients App 20020156125 - Broder, Samuel ; et al.	2002-10-24
Method and compositions for administering taxanes orally to human patients Grant 6,395,770 - Broder , et al. May 28, 2	2002-05-28
Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents App 20020058616 - Broder, Samuel ; et al.	2002-05-16
Methods and compositions for treatment of asthma Grant 6,284,800 - Broder , et al. September 4, 2	2001-09-04
Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents Grant 6,245,805 - Broder , et al. June 12, 2	2001-06-12
Method for increasing the oral bioactivity of pharmaceutical agents Grant 5,968,972 - Broder , et al. October 19, 1	1999-10-19
Method for treating asthma Grant 5,690,910 - Ahmed , et al. November 25, 1	1997-11-25
Method of inhibiting HIV replication with 2',3'-dideoxyadenosine Grant 5,616,566 - Mitsuya , et al. April 1, 1	1997-04-01
Treatment of retroviral induced dementia by administration of 2',3'-dideoxyinosine Grant 5,376,642 - Yarchoan , et al. December 27, 1	1994-12-27
Method of treating HIV with 2',3'-dideoxyinosine Grant 5,254,539 - Mitsuya , et al. * October 19, 1	1993-10-19
Anti-retroviral compounds Grant RE33,887 - Tam , et al. April 14, 1	1992-04-14
Treatment of human retroviral infections with 2',3'-dideoxyinosine alone and in combination with other antiviral compounds Grant 5,026,687 - Yarchoan , et al. June 25, 1	1991-06-25
Therapeutic application of dideoxycytidinene Grant 4,963,533 - de Clercq , et al. October 16, 1	1990-10-16
Antiviral compositions and methods Grant 4,879,277 - Mitsuya , et al. November 7, 1	1989-11-07
Antiviral compositions and methods Grant 4,861,759 - Mitsuya , et al. August 29, 1	1989-08-29
Cell line producing human monoclonal antibody which binds to HTLV-I producing cells Grant 4,722,888 - Broder , et al. February 2, 1	1988-02-02
Immortalized T-lymphocyte cell line for testing HTLV-III inactivation Grant 4,704,357 - Mitsuya , et al. November 3, 1	1987-11-03

Company Registrations

SEC

0001340543

Broder Samuel

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.